Omalizumab
CAS No. 242138-07-4
Omalizumab ( —— )
Catalog No. M22157 CAS No. 242138-07-4
Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 455 | In Stock |
|
10MG | 659 | In Stock |
|
25MG | 981 | In Stock |
|
50MG | 1341 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOmalizumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionOmalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).
-
DescriptionOmalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number242138-07-4
-
Formula Weight149 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chan MA, et al.Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells.Clin Transl Allergy. 2013 Sep 2;3(1):29.
molnova catalog
related products
-
5-Hydroxyflavone
5-Hydroxyflavone is a natural product.
-
Nauclefine
Nauclefine
-
TRAM-34
TRAM-34(Kd=20 nM), an effective and specific inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1), does not block cytochrome P450.